19148667

Source:http://linkedlifedata.com/resource/pubmed/id/19148667

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0031740, umls-concept:C0034897, umls-concept:C0205269, umls-concept:C0600518, umls-concept:C0796392, umls-concept:C1517572, umls-concept:C1656863
pubmed:issue	5
pubmed:dateCreated	2009-4-2
pubmed:abstractText	To examine the effect of intravitreal injections of bevacizumab for myopic choroidal neovascularization (myopic CNV) that was refractory to or recurred after photodynamic therapy (PDT).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8205248
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1435-702X
pubmed:author	pubmed-author:HaraWakakoW, pubmed-author:HayashiKengoK, pubmed-author:MochizukiManabuM, pubmed-author:MoriyamaMukaM, pubmed-author:Ohno-MatsuiKyokoK, pubmed-author:ShimadaNoriakiN, pubmed-author:TokoroTakashiT, pubmed-author:YoshidaTakeshiT
pubmed:issnType	Electronic
pubmed:volume	247
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	609-18
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:19148667-Adult, pubmed-meshheading:19148667-Aged, pubmed-meshheading:19148667-Angiogenesis Inhibitors, pubmed-meshheading:19148667-Antibodies, Monoclonal, pubmed-meshheading:19148667-Antibodies, Monoclonal, Humanized, pubmed-meshheading:19148667-Choroidal Neovascularization, pubmed-meshheading:19148667-Female, pubmed-meshheading:19148667-Fluorescein Angiography, pubmed-meshheading:19148667-Follow-Up Studies, pubmed-meshheading:19148667-Humans, pubmed-meshheading:19148667-Injections, pubmed-meshheading:19148667-Male, pubmed-meshheading:19148667-Middle Aged, pubmed-meshheading:19148667-Myopia, Degenerative, pubmed-meshheading:19148667-Photochemotherapy, pubmed-meshheading:19148667-Prospective Studies, pubmed-meshheading:19148667-Recurrence, pubmed-meshheading:19148667-Treatment Outcome, pubmed-meshheading:19148667-Vascular Endothelial Growth Factor A, pubmed-meshheading:19148667-Visual Acuity, pubmed-meshheading:19148667-Vitreous Body
pubmed:year	2009
pubmed:articleTitle	Intravitreal bevacizumab on myopic choroidal neovascularization that was refractory to or had recurred after photodynamic therapy.
pubmed:affiliation	Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't